CN103037858A - 用于预防和治疗接触镜致乳头性结膜炎以及过敏性眼病的组合物 - Google Patents

用于预防和治疗接触镜致乳头性结膜炎以及过敏性眼病的组合物 Download PDF

Info

Publication number
CN103037858A
CN103037858A CN2011800379582A CN201180037958A CN103037858A CN 103037858 A CN103037858 A CN 103037858A CN 2011800379582 A CN2011800379582 A CN 2011800379582A CN 201180037958 A CN201180037958 A CN 201180037958A CN 103037858 A CN103037858 A CN 103037858A
Authority
CN
China
Prior art keywords
dexpanthenol
contact lens
composition
papillary conjunctivitis
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2011800379582A
Other languages
English (en)
Chinese (zh)
Inventor
布莱恩·安东尼·霍尔登
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brien Holden Vision Institute Ltd
Original Assignee
Brien Holden Vision Institute Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2010902954A external-priority patent/AU2010902954A0/en
Application filed by Brien Holden Vision Institute Ltd filed Critical Brien Holden Vision Institute Ltd
Publication of CN103037858A publication Critical patent/CN103037858A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Eyeglasses (AREA)
CN2011800379582A 2010-07-02 2011-07-01 用于预防和治疗接触镜致乳头性结膜炎以及过敏性眼病的组合物 Pending CN103037858A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2010902954 2010-07-02
AU2010902954A AU2010902954A0 (en) 2010-07-02 Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease
PCT/AU2011/000827 WO2012000055A1 (en) 2010-07-02 2011-07-01 Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease

Publications (1)

Publication Number Publication Date
CN103037858A true CN103037858A (zh) 2013-04-10

Family

ID=45401233

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011800379582A Pending CN103037858A (zh) 2010-07-02 2011-07-01 用于预防和治疗接触镜致乳头性结膜炎以及过敏性眼病的组合物

Country Status (9)

Country Link
US (2) US9161923B2 (https=)
EP (1) EP2588096A4 (https=)
JP (1) JP2013534527A (https=)
CN (1) CN103037858A (https=)
AU (1) AU2011274245B2 (https=)
CA (1) CA2803935A1 (https=)
SG (1) SG186782A1 (https=)
TW (1) TW201206418A (https=)
WO (1) WO2012000055A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101801521B (zh) 2007-05-14 2015-06-17 纽约州立大学研究基金会 生物膜中细菌细胞内的生理学分散响应诱导
WO2012000055A1 (en) * 2010-07-02 2012-01-05 Brien Holden Vision Institute Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease
AR089518A1 (es) * 2012-12-27 2014-08-27 Vega Villavicencio Parsival Costra artificial porosa semipermeable
HUE044329T2 (hu) * 2014-01-22 2019-10-28 Visufarma B V Iota-karragént tartalmazó készítmény vírusos kötõhártya-gyulladás ellen
SG11201700484SA (en) * 2014-08-08 2017-02-27 Shenzhen Hightide Biopharmaceutical Ltd Liquid formulation compositions, medicament delivery devices, and methods of preparation and use thereof
PL3072503T3 (pl) * 2015-03-26 2021-01-11 D.M.G. Italia Srl Kompozycja okulistyczna do ochrony rogówki
EP3496516B1 (en) 2017-12-11 2020-02-19 Ion Beam Applications S.A. Superconductor cyclotron regenerator
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
EP3827818A1 (en) * 2019-11-26 2021-06-02 Warszawskie Zaklady Farmaceutyczne Polfa S.A. Ophthalmic composition
WO2025253406A1 (en) * 2024-06-05 2025-12-11 Sentiss Pharma Private Limited Dexpanthenol gel forming solution and method of preparation thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1484536A (zh) * 2001-01-12 2004-03-24 ��˹��ŵ�� 含有右泛醇的镜片护理产品
US20050164979A1 (en) * 2001-12-12 2005-07-28 Dorothea Gross Pharmaceutical composition for ophthalmological and rhinological application
WO2009094466A2 (en) * 2008-01-22 2009-07-30 University Of Florida Research Foundation, Inc. Contact lenses for extended release of bioactive agents containing diffusion attenuators
WO2010056113A1 (en) * 2008-11-17 2010-05-20 Louis Johan Wagenaar Ophthalmic solutions, including contact lens care solutions and eye drops comprising carnosine, preferably in combination with dexpanthenol and/or hyaluronic acid

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6211238B1 (en) * 1998-10-27 2001-04-03 Alcon Laboratories, Inc. Preservative system for topically administrable pharmaceutical compositions
US20070104744A1 (en) * 2000-11-08 2007-05-10 Fxs Ventures, Llc Ophthalmic and contact lens solutions containing forms of vitamin b
DK1347787T4 (da) * 2001-01-09 2011-01-03 Louis Johan Wagenaar Anvendelse af dexpanthenol i kontaktlinse-plejesammensætninger
US20050220742A1 (en) 2004-03-31 2005-10-06 Breen Ed V Compositions and methods for maintaining eyelid hygiene
US20070243275A1 (en) 2006-04-13 2007-10-18 Gilbard Jeffrey P Methods and compositions for the treatment of infection or infectious colonization of the eyelid, ocular surface, skin or ear
US20100087550A1 (en) * 2008-10-06 2010-04-08 Zora Marlowe Formulations with a Tertiary Amine Oxide
LT2424374T (lt) 2009-05-01 2018-04-25 Advanced Vision Research, Inc. Valiklio kompozicijos ir jų panaudojimo būdai
IT1393712B1 (it) 2009-05-13 2012-05-08 Bruschettini Srl Composizioni oftalmiche per la riepitelizzazione, la cicatrizzazione, e la disinfezione dei tessuti oculari
WO2012000055A1 (en) * 2010-07-02 2012-01-05 Brien Holden Vision Institute Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1484536A (zh) * 2001-01-12 2004-03-24 ��˹��ŵ�� 含有右泛醇的镜片护理产品
US20050164979A1 (en) * 2001-12-12 2005-07-28 Dorothea Gross Pharmaceutical composition for ophthalmological and rhinological application
WO2009094466A2 (en) * 2008-01-22 2009-07-30 University Of Florida Research Foundation, Inc. Contact lenses for extended release of bioactive agents containing diffusion attenuators
WO2010056113A1 (en) * 2008-11-17 2010-05-20 Louis Johan Wagenaar Ophthalmic solutions, including contact lens care solutions and eye drops comprising carnosine, preferably in combination with dexpanthenol and/or hyaluronic acid

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
无: "PAN-OPHTAL AUGENTROPFEN", 《HTTPS://WWW.ALIVA.DE/IMAGES/ECOMMERCE/07/13/07136903_2005-06_DE_O.PDF》 *
无: "Pan-Ophtal Gebrauchsinformation: Information fUr den Anwender Pan-Ophthal gel", 《URL:HTTPS://WWW.ALIVA.DE/IMAGES/ECOMMERCE/02/00/02003563_2006-06_DE_O.PDF》 *
杉田美由纪: "《白内障、青光眼、糖尿病性视网膜病变》", 28 February 2010, 吉林科学技术出版社 *

Also Published As

Publication number Publication date
AU2011274245B2 (en) 2014-07-17
JP2013534527A (ja) 2013-09-05
US20130102679A1 (en) 2013-04-25
SG186782A1 (en) 2013-02-28
CA2803935A1 (en) 2012-01-05
US20160074345A1 (en) 2016-03-17
AU2011274245A1 (en) 2013-01-10
EP2588096A4 (en) 2013-12-25
TW201206418A (en) 2012-02-16
EP2588096A1 (en) 2013-05-08
WO2012000055A1 (en) 2012-01-05
US9161923B2 (en) 2015-10-20

Similar Documents

Publication Publication Date Title
AU2011274245B2 (en) Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease
US20250049761A1 (en) Compositions and methods for treating presbyopia, mild hyperopia, and irregular astigmatism
KR102600484B1 (ko) 노안의 치료를 위한 조성물 및 방법
ES2461617T3 (es) Composiciones farmacéuticas acuosas que contienen complejos borato-polioles
TWI650122B (zh) 用於預防及／或治療乾眼症之組成物、方法及／或裝置
ES2709180T3 (es) Soluciones de brimonidina y timolol sin conservantes
ES2708451T3 (es) Soluciones de bimatoprost y timolol sin conservantes
ES3014823T3 (en) Ophthalmic formulations of cetirizine and methods of use
ES2604816B1 (es) Composición farmacéutica de tramadol para uso oftálmico
WO2023024126A1 (zh) 一种含伏立康唑的眼用凝胶剂及其制备方法与应用
CA2453442A1 (en) Compositions and methods of administering tubulin binding agents for the treatment of ocular diseases
HK1182338A (en) Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease
ES2652024T3 (es) Gotas para los ojos para el tratamiento de la conjuntivocalasis
CA3178254A1 (en) Low-dose carbachol compositions and methods for treatment of night vision disturbance
NZ623037B2 (en) Compositions and methods for treating presbyopia, mild hyperopia, and irregular astigmatism

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1182338

Country of ref document: HK

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20130410

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1182338

Country of ref document: HK